1stOncology™: Cancer Intelligence Service – Page 9431 – 1stOncology is recognized as a Top 10 Global Pharma Analytic Provider

Lilly to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

On September 3, 2021 Eli Lilly and Company (NYSE: LLY) reported that it will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on Tuesday, September 14, 2021 (Press release, Eli Lilly, SEP 3, 2021, View Source [SID1234587229]). Michael Mason, senior vice president, president of Lilly Diabetes, will participate in a virtual fireside chat at 1:15 p.m., Eastern Time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly’s Investor website at View Source A replay of the presentation will be available on this same website for approximately 90 days.

Bellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference

On September 3, 2021 Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, reported that Rick Fair, President and CEO, will participate in the H.C. Wainwright 23rd Annual Global Investment Conference (Virtual) (Press release, Bellicum Pharmaceuticals, SEP 3, 2021, View Source [SID1234587226]). A pre-recorded presentation will be available to view on-demand beginning at 7 a.m. ET / 4 a.m. PT on September 13, 2021 and will remain accessible for 90 days in the Events and Presentations section of the Bellicum website.

Amgen to Present at the 16th Annual Citi BioPharma Conference

On September 3, 2021 Amgen (NASDAQ:AMGN) reported that it will present at Citi’s 16th Annual BioPharma Conference at 1:25 p.m. ET on Wednesday, Sept. 8, 2021 (Press release, Amgen, SEP 3, 2021, View Source [SID1234587225]). Murdo Gordon, executive vice president of Global Commercial Operations at Amgen will present at the conference. Live audio of the conference call will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen’s business given at certain investor and medical conferences, can be accessed on Amgen’s website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen’s Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

ImmunoPrecise Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2022

On September 3, 2021 IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development, reported that it will host a conference call to discuss its financial results and recent business highlights for first quarter fiscal year 2022, on September 9, 2021, after the close of market (Press release, ImmunoPrecise Antibodies, SEP 3, 2021, View Source [SID1234587223]). The financial results will be issued in a press release prior to the call. ImmunoPrecise management will host the conference call followed by a pre-submitted question-and-answer period. Investors interested in submitting questions ahead of the call are encouraged to email the Company’s investor relations representative.

Conference Call:

The conference call will be webcast live and available for replay via a link provided in the Events section of the company’s IR pages at View Source

Please call the conference telephone number five minutes prior to the start time. An operator will register your name and organization.

Anyone listening to the call is encouraged to read the company’s periodic reports on file with the Toronto Stock Exchange and Securities and Exchange Commission, including the discussion of risk factors and historical results of operations and financial condition in those reports.

Concert Pharmaceuticals to Present at Upcoming Investor Conferences

On September 3, 2021 Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) reported that it will participate virtually at the following upcoming investor conferences (Press release, Concert Pharmaceuticals, SEP 3, 2021, View Source [SID1234587220]):

The H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021, on-demand beginning at 7:00 a.m. ET; and
The Cantor Virtual Global Healthcare Conference on September 30, 2021 at 3:20 p.m. ET.
Webcasts of the presentations may be accessed in the Investors section of the Company’s website at www.concertpharma.com. A replay of the conference webcasts will be available on Concert’s website for two weeks following the presentations.